Published: 11 March 2024
Author(s): Francesco Santoro, Ivan J. Núñez-Gil, María C. Viana-Llamas, Emilio Alfonso-Rodríguez, Aitor Uribarri, Victor Manuel Becerra-Muñoz, Gisela Feltes Guzman, Nicola Di Nunno, Javier Lopez-Pais, Enrico Cerrato, Gianfranco Sinagra, Massimo Mapelli, Riccardo M. Inciardi, Claudia Specchia, Chiara Oriecuia, Natale Daniele Brunetti
Issue: May 2024
Section: Original Article

COVID-19 is an infectious disease that has become pandemic from 2020. Data on acute outcome, showed that among hospitalized patients mortality rates were 15.8 % in USA[1] and 22 % in Europe [2,3]. Long term consequences of COVID have been described as persistence of COVID-19 symptoms beyond 3 months and named as Long-COVID [4]. Cardiac symptoms as shortness of breath, chest pain, fatigue, and postural orthostatic tachycardia have been described [5]. Moreover, several cardiovascular (CV) diseases have been reported after the acute phase including myocardial inflammation, myocardial and brain infarction, and venous thrombosis [6].

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness